{
    "title": "EXPLAINER-What we know about China-made vaccines",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9101833/EXPLAINER-What-know-China-vaccines.html",
    "date": "2020-12-31",
    "keywords": [
        "efficacy",
        "vaccine",
        "china",
        "thursday",
        "rate",
        "shot",
        "sinopharm",
        "cansinobio",
        "trial",
        "sinovacs",
        "coronavac",
        "dec",
        "year",
        "approval",
        "timeline",
        "arab",
        "executive",
        "turkey",
        "brazil",
        "mexico",
        "health",
        "official",
        "use",
        "programme",
        "month",
        "technology",
        "occurrence",
        "deal",
        "supply",
        "race",
        "stage",
        "homemade",
        "development",
        "group",
        "academy",
        "none",
        "affiliate",
        "day",
        "developer",
        "analysis",
        "phase",
        "reading",
        "candidate",
        "success",
        "jan",
        "week",
        "covid19",
        "latestage",
        "emergency",
        "july",
        "risk",
        "infection",
        "anticipation",
        "transmission",
        "winter",
        "morning",
        "post",
        "newspaper",
        "lunar",
        "holiday",
        "virus",
        "response",
        "allergy",
        "administration",
        "yixin",
        "country",
        "public",
        "pakistan",
        "purchase",
        "indonesia",
        "chile",
        "company",
        "malaysia",
        "president",
        "jinping",
        "reporting",
        "miyoung",
        "kim",
        "roxanne",
        "liu",
        "birsel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}